{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:27:18Z","timestamp":1790324838592,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:00:00Z","timestamp":1447113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/npp.2015.340","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T12:01:00Z","timestamp":1447156860000},"page":"1742-1750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers"],"prefix":"10.1038","volume":"41","author":[{"given":"Inge","family":"Mick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R A","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erritzoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Colasanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger N","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-6687","authenticated-orcid":false,"given":"Eugenii A","family":"Rabiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham E","family":"Searle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D","family":"Waldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D","family":"Brailsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C F","family":"Galdur\u00f3z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Bowden-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne R","family":"Lingford-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,10]]},"reference":[{"key":"BFnpp2015340_CR1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1586\/14737175.2013.814938","volume":"13","author":"CA Bartley","year":"2013","unstructured":"Bartley CA, Bloch MH (2013). Meta-analysis: pharmacological treatment of pathological gambling. Expert Rev Neurother 13: 887\u2013894.","journal-title":"Expert Rev Neurother"},{"key":"BFnpp2015340_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF01019930","volume":"2","author":"APW Blaszczynski","year":"1986","unstructured":"Blaszczynski APW, Simon W, McConaghy Neil (1986). Plasma endorphin levels in pathological gambling. J Gambl Behav 2: 3\u201314.","journal-title":"J Gambl Behav"},{"key":"BFnpp2015340_CR3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/mp.2013.163","volume":"19","author":"I Boileau","year":"2013","unstructured":"Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA et al (2013). In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [C]-(+)-PHNO. Mol Psychiatry 19: 1305\u20131313.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2015340_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.tins.2012.06.007","volume":"35","author":"R Bourdy","year":"2012","unstructured":"Bourdy R, Barrot M (2012). A new control center for dopaminergic systems: pulling the VTA by the tail. Trends Neurosci 35: 681\u2013690.","journal-title":"Trends Neurosci"},{"key":"BFnpp2015340_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1192\/bjp.bp.110.088146","volume":"199","author":"H Bowden-Jones","year":"2011","unstructured":"Bowden-Jones H, Clark L (2011). Pathological gambling: a neurobiological and clinical update. Br J Psychiatry 199: 87\u201389.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2015340_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.conb.2013.01.004","volume":"23","author":"L Clark","year":"2013","unstructured":"Clark L, Limbrick-Oldfield EH (2013). Disordered gambling: a behavioral addiction. Curr Opin Neurobiol 23: 655\u2013659.","journal-title":"Curr Opin Neurobiol"},{"key":"BFnpp2015340_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neuroimage.2012.06.067","volume":"63","author":"L Clark","year":"2012","unstructured":"Clark L, Stokes PR, Wu K, Michalczuk R, Benecke A, Watson BJ et al (2012). Striatal dopamine D(2)\/D(3) receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage 63: 40\u201346.","journal-title":"Neuroimage"},{"key":"BFnpp2015340_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.biopsych.2012.01.027","volume":"72","author":"A Colasanti","year":"2012","unstructured":"Colasanti A, Searle GE, Long CJ, Hill SP, Reiley RR, Quelch D et al (2012). Endogenous opioid release in the human brain reward system induced by acute amphetamine administration. Biol Psychiatry 72: 371\u2013377.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2015340_CR9","first-page":"CD008937","volume":"11","author":"S Cowlishaw","year":"2012","unstructured":"Cowlishaw S, Merkouris S, Dowling N, Anderson C, Jackson A, Thomas S (2012). Psychological therapies for pathological and problem gambling. Cochrane Database Syst Rev 11: CD008937.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFnpp2015340_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1037\/1040-3590.19.1.107","volume":"19","author":"MA Cyders","year":"2007","unstructured":"Cyders MA, Smith GT, Spillane NS, Fischer S, Annus AM, Peterson C (2007). Integration of impulsivity and positive mood to predict risky behavior: development and validation of a measure of positive urgency. Psychol Assess 19: 107\u2013118.","journal-title":"Psychol Assess"},{"key":"BFnpp2015340_CR11","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/01.wnr.0000234755.88560.c7","volume":"17","author":"R Doron","year":"2006","unstructured":"Doron R, Fridman L, Yadid G (2006). Dopamine-2 receptors in the arcuate nucleus modulate cocaine-seeking behavior. Neuroreport 17: 1633\u20131636.","journal-title":"Neuroreport"},{"key":"BFnpp2015340_CR12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/npp.2014.18","volume":"39","author":"D Erritzoe","year":"2014","unstructured":"Erritzoe D, Tziortzi A, Bargiela D, Colasanti A, Searle GE, Gunn RN et al (2014). In vivo imaging of cerebral dopamine D3 receptors in alcoholism. Neuropsychopharmacology 39: 1703\u20131712.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015340_CR13","volume-title":"Canadian Problem Gambling Index","author":"J Ferris","year":"2001","unstructured":"Ferris J, Wynne H (2001) Canadian Problem Gambling Index. Canadian Centre on Substance Abuse: Ottawa, Ontario."},{"key":"BFnpp2015340_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.aucc.2010.03.001","volume":"23","author":"J Fethney","year":"2010","unstructured":"Fethney J (2010). Statistical and clinical significance, and how to use confidence intervals to help interpret both. Aust Crit Care 23: 93\u201397.","journal-title":"Aust Crit Care"},{"key":"BFnpp2015340_CR15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1017\/S1092852900016424","volume":"13","author":"KT Forbush","year":"2008","unstructured":"Forbush KT, Shaw M, Graeber MA, Hovick L, Meyer VJ, Moser DJ et al (2008). Neuropsychological characteristics and personality traits in pathological gambling. CNS Spectr 13: 306\u2013315.","journal-title":"CNS Spectr"},{"key":"BFnpp2015340_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1017\/S1355617706061091","volume":"12","author":"D Fuentes","year":"2006","unstructured":"Fuentes D, Tavares H, Artes R, Gorenstein C (2006). Self-reported and neuropsychological measures of impulsivity in pathological gambling. J Int Neuropsychol Soc 12: 907\u2013912.","journal-title":"J Int Neuropsychol Soc"},{"key":"BFnpp2015340_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.biopsych.2010.05.003","volume":"68","author":"UE Ghitza","year":"2010","unstructured":"Ghitza UE, Preston KL, Epstein DH, Kuwabara H, Endres CJ, Bencherif B et al (2010). Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry 68: 697\u2013703.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2015340_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/oxfordjournals.alcalc.a008216","volume":"31 Suppl 1","author":"C Gianoulakis","year":"1996","unstructured":"Gianoulakis C (1996). Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies. Alcohol Alcohol 31 Suppl 1: 33\u201342.","journal-title":"Alcohol Alcohol"},{"key":"BFnpp2015340_CR19","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.biopsych.2005.02.026","volume":"57","author":"DA Gorelick","year":"2005","unstructured":"Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M et al (2005). Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry 57: 1573\u20131582.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2015340_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00213-008-1225-5","volume":"200","author":"DA Gorelick","year":"2008","unstructured":"Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino ML et al (2008). Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence. Psychopharmacology 200: 475\u2013486.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015340_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00213-008-1235-3","volume":"200","author":"JE Grant","year":"2008","unstructured":"Grant JE, Kim SW, Hollander E, Potenza MN (2008). Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology 200: 521\u2013527.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015340_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2125.2012.04457.x","volume":"77","author":"JE Grant","year":"2014","unstructured":"Grant JE, Odlaug BL, Schreiber LR (2014). Pharmacological treatments in pathological gambling. Br J Clin Pharmacol 77: 375\u2013381.","journal-title":"Br J Clin Pharmacol"},{"key":"BFnpp2015340_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archpsyc.62.1.57","volume":"62","author":"A Heinz","year":"2005","unstructured":"Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G et al (2005). Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 62: 57\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2015340_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00259-008-0935-6","volume":"36","author":"J Hirvonen","year":"2009","unstructured":"Hirvonen J, Aalto S, Hagelberg N, Maksimow A, Ingman K, Oikonen V et al (2009). Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects. Eur J Nucl Med Mol Imaging 36: 275\u2013286.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFnpp2015340_CR25","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/S0140-6736(10)62185-X","volume":"378","author":"DC Hodgins","year":"2011","unstructured":"Hodgins DC, Stea JN, Grant JE (2011). Gambling disorders. Lancet 378: 1874\u20131884.","journal-title":"Lancet"},{"key":"BFnpp2015340_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","volume":"12","author":"SW Johnson","year":"1992","unstructured":"Johnson SW, North RA (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483\u2013488.","journal-title":"J Neurosci"},{"key":"BFnpp2015340_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1177\/0269881112444324","volume":"26","author":"AR Lingford-Hughes","year":"2012","unstructured":"Lingford-Hughes AR, Welch S, Peters L, Nutt DJ (2012). BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol 26: 899\u2013952.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2015340_CR28","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/archgenpsychiatry.2009.134","volume":"66","author":"TM Love","year":"2009","unstructured":"Love TM, Stohler CS, Zubieta JK (2009). Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch Gen Psychiatry 66: 1124\u20131134.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2015340_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1177\/0269881107083846","volume":"22","author":"DI Lubman","year":"2008","unstructured":"Lubman DI, Allen NB, Peters LA, Deakin JF (2008). Electrophysiological evidence that drug cues have greater salience than other affective stimuli in opiate addiction. J Psychopharmacol 22: 836\u2013842.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2015340_CR30","first-page":"308","volume":"11","author":"A Mansour","year":"1988","unstructured":"Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988). Anatomy of CNS opioid receptors. TrendsNeurosci 11: 308\u2013314.","journal-title":"TrendsNeurosci"},{"key":"BFnpp2015340_CR31","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.psyneuen.2004.03.005","volume":"29","author":"G Meyer","year":"2004","unstructured":"Meyer G, Schwertfeger J, Exton MS, Janssen OE, Knapp W, Stadler MA et al (2004). Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology 29: 1272\u20131280.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2015340_CR32","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1017\/S003329171100095X","volume":"41","author":"R Michalczuk","year":"2011","unstructured":"Michalczuk R, Bowden-Jones H, Verdejo-Garcia A, Clark L (2011). Impulsivity and cognitive distortions in pathological gamblers attending the UK National Problem Gambling Clinic: a preliminary report. Psychol Med 41: 2625\u20132635.","journal-title":"Psychol Med"},{"key":"BFnpp2015340_CR33","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1017\/S1461145714000704","volume":"17","author":"I Mick","year":"2014","unstructured":"Mick I, Myers J, Stokes PR, Erritzoe D, Colasanti A, Bowden-Jones H et al (2014). Amphetamine induced endogenous opioid release in the human brain detected with [11C]carfentanil PET: replication in an independent cohort. Int J Neuropsychopharmacol 17: 2069\u20132074.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2015340_CR34","doi-asserted-by":"publisher","first-page":"10509","DOI":"10.1523\/JNEUROSCI.2807-08.2008","volume":"28","author":"P Petrovic","year":"2008","unstructured":"Petrovic P, Pleger B, Seymour B, Kloppel S, De Martino B, Critchley H et al (2008). Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses. J Neurosci 28: 10509\u201310516.","journal-title":"J Neurosci"},{"key":"BFnpp2015340_CR35","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1098\/rstb.2008.0100","volume":"363","author":"MN Potenza","year":"2008","unstructured":"Potenza MN (2008). Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos TransR Soc Lond B Biol Sci 363: 3181\u20133189.","journal-title":"Philos TransR Soc Lond B Biol Sci"},{"key":"BFnpp2015340_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF02104901","volume":"10","author":"HJ Shaffer","year":"1994","unstructured":"Shaffer HJ, Labrie R, Scanlan KM, Cummings TN (1994). Pathological gambling among adolescents: Massachusetts Gambling Screen (MAGS). J Gambl Stud 10: 339\u2013362.","journal-title":"J Gambl Stud"},{"key":"BFnpp2015340_CR37","first-page":"22","volume":"59 Suppl 20","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20: 22\u201333.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2015340_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2114\/jpa.18.37","volume":"18","author":"K Shinohara","year":"1999","unstructured":"Shinohara K, Yanagisawa A, Kagota Y, Gomi A, Nemoto K, Moriya E et al (1999). Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate. Appl Human Sci 18: 37\u201342.","journal-title":"Appl Human Sci"},{"key":"BFnpp2015340_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.brainres.2009.08.035","volume":"1296","author":"AR Soderman","year":"2009","unstructured":"Soderman AR, Unterwald EM (2009). Cocaine-induced mu opioid receptor occupancy within the striatum is mediated by dopamine D2 receptors. Brain Res 1296: 63\u201371.","journal-title":"Brain Res"},{"key":"BFnpp2015340_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1021\/jm9903702","volume":"43","author":"G Subramanian","year":"2000","unstructured":"Subramanian G, Paterlini MG, Portoghese PS, Ferguson DM (2000). Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. J Med Chem 43: 381\u2013391.","journal-title":"J Med Chem"},{"key":"BFnpp2015340_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0014-2999(89)90582-7","volume":"167","author":"M Titeler","year":"1989","unstructured":"Titeler M, Lyon RA, Kuhar MJ, Frost JF, Dannals RF, Leonhardt S et al (1989). Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain. Eur J Pharmacol 167: 221\u2013228.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2015340_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","volume":"54","author":"AC Tziortzi","year":"2011","unstructured":"Tziortzi AC, Searle GE, Tzimopoulou S, Salinas C, Beaver JD, Jenkinson M et al (2011). Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage 54: 264\u2013277.","journal-title":"Neuroimage"},{"key":"BFnpp2015340_CR43","first-page":"5","volume":"56 Suppl 7","author":"RR Ulm","year":"1995","unstructured":"Ulm RR, Volpicelli JR, Volpicelli LA (1995). Opiates and alcohol self-administration in animals. J Clin Psychiatry 56 Suppl 7: 5\u201314.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2015340_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neubiorev.2009.07.007","volume":"34","author":"RJ van Holst","year":"2010","unstructured":"van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE (2010). Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neurosci Biobehav Rev 34: 87\u2013107.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2015340_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF00428897","volume":"44","author":"DP Van Kammen","year":"1975","unstructured":"Van Kammen DP, Murphy DL (1975). Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44: 215\u2013224.","journal-title":"Psychopharmacologia"},{"key":"BFnpp2015340_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.neubiorev.2007.11.003","volume":"32","author":"A Verdejo-Garcia","year":"2008","unstructured":"Verdejo-Garcia A, Lawrence AJ, Clark L (2008). Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 32: 777\u2013810.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2015340_CR47","doi-asserted-by":"publisher","first-page":"e89954","DOI":"10.1371\/journal.pone.0089954","volume":"9","author":"M Votinov","year":"2014","unstructured":"Votinov M, Pripfl J, Windischberger C, Kalcher K, Zimprich A, Zimprich F et al (2014). A genetic polymorphism of the endogenous opioid dynorphin modulates monetary reward anticipation in the corticostriatal loop. PLoS One 9: e89954.","journal-title":"PLoS One"},{"key":"BFnpp2015340_CR48","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0191-8869(00)00064-7","volume":"30","author":"SP Whiteside","year":"2001","unstructured":"Whiteside SP, Lynam DR (2001). The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity. Pers Individ Dif 30: 669\u2013689.","journal-title":"Pers Individ Dif"},{"key":"BFnpp2015340_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1192\/bjp.bp.106.031120","volume":"191","author":"TM Williams","year":"2007","unstructured":"Williams TM, Daglish MR, Lingford-Hughes A, Taylor LG, Hammers A, Brooks DJ et al (2007). Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography study. Br J Psychiatry 191: 63\u201369.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2015340_CR50","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.euroneuro.2009.06.007","volume":"19","author":"TM Williams","year":"2009","unstructured":"Williams TM, Davies SJ, Taylor LG, Daglish MR, Hammers A, Brooks DJ et al (2009). Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study. Eur Neuropsychopharmacol 19: 740\u2013748.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2015340_CR51","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1037\/a0015043","volume":"23","author":"MM Young","year":"2009","unstructured":"Young MM, Wohl MJ (2009). The Gambling Craving Scale: psychometric validation and behavioral outcomes. Psychol Addict Behav 23: 512\u2013522.","journal-title":"Psychol Addict Behav"},{"key":"BFnpp2015340_CR52","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/nm1196-1225","volume":"2","author":"JK Zubieta","year":"1996","unstructured":"Zubieta JK, Gorelick DA, Stauffer R, Ravert HT, Dannals RF, Frost JJ (1996). Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med 2: 1225\u20131229.","journal-title":"Nat Med"},{"key":"BFnpp2015340_CR53","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/archpsyc.60.11.1145","volume":"60","author":"JK Zubieta","year":"2003","unstructured":"Zubieta JK, Ketter TA, Bueller JA, Xu Y, Kilbourn MR, Young EA et al (2003). Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry 60: 1145\u20131153.","journal-title":"Arch Gen Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2015340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2015340","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2015340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:53:40Z","timestamp":1684454020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2015340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,10]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFnpp2015340"],"URL":"https:\/\/doi.org\/10.1038\/npp.2015.340","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,10]]},"assertion":[{"value":"29 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}